While global cancer cases continue to rise around the world, the fight is personal not only for patients and their loved ones but also for the scientific community.
“Cancer is like a personal terrorist…it starts small and attempts a hostile takeover of your entire body. It consumes your person from the inside out, racing through your system and showing no mercy. It uses force and fear and violence to control you. It tries to claim your body, your life, your time and your dignity…”
There is perhaps no better view into what a person fighting cancer faces than the words of someone who has lived with it…someone like Jamie Goldfarb. And there’s also no better inspiration for innovative biomedical research companies like Merck to fight harder than ever on their behalf.
“We have all been affected by cancer, whether through family, friends, neighbors, colleagues — or even personally. The chance to have a broad impact on Jamie and the millions of people like her is driving all of us in the scientific community. It’s more than work — it’s a passion, and it’s personal,” said Frank Clyburn, president, Merck Oncology. “Together, we hope to make it possible to help alter the prognoses of those suffering with cancer.”
The impact of cancer is astounding. Chances are you know someone — likely more than one person — who has been afflicted with the disease. Consider:
In 2012, it is estimated that more than 14 million people worldwide learned they had cancer
In 2012, it is estimated that more than 8 million people worldwide died from cancer
By 2025, new cancer cases worldwide are predicted to exceed 20 million annually
“Something about the disease, which is random, through no fault of anyone, it strikes a person, it doesn't pick gender, ethnicity, it's indiscriminate…”
“It's important for medical researchers to keep going and keep pushing innovation forward.”